A detailed history of Mc Guire Investment Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Mc Guire Investment Group, LLC holds 14,185 shares of AMGN stock, worth $3.74 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
14,185
Previous 14,306 0.85%
Holding current value
$3.74 Million
Previous $4.47 Million 2.26%
% of portfolio
0.65%
Previous 0.65%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$309.38 - $337.38 $37,434 - $40,822
-121 Reduced 0.85%
14,185 $4.57 Million
Q2 2024

Jul 23, 2024

SELL
$262.75 - $319.31 $5,780 - $7,024
-22 Reduced 0.15%
14,306 $4.47 Million
Q1 2024

Apr 26, 2024

SELL
$268.87 - $324.56 $87,113 - $105,157
-324 Reduced 2.21%
14,328 $4.07 Million
Q4 2023

Jan 12, 2024

SELL
$255.7 - $288.46 $153,164 - $172,787
-599 Reduced 3.93%
14,652 $4.22 Million
Q3 2023

Oct 12, 2023

SELL
$218.65 - $271.46 $123,537 - $153,374
-565 Reduced 3.57%
15,251 $4.1 Million
Q2 2023

Jul 18, 2023

SELL
$214.27 - $253.37 $131,133 - $155,062
-612 Reduced 3.73%
15,816 $3.51 Million
Q1 2023

Apr 20, 2023

SELL
$225.79 - $275.2 $169,116 - $206,124
-749 Reduced 4.36%
16,428 $3.97 Million
Q4 2022

Jan 10, 2023

SELL
$229.03 - $291.01 $5,725 - $7,275
-25 Reduced 0.15%
17,177 $0
Q3 2022

Oct 13, 2022

SELL
$224.46 - $253.15 $25,139 - $28,352
-112 Reduced 0.65%
17,202 $3.88 Million
Q2 2022

Jul 15, 2022

SELL
$230.71 - $256.74 $81,209 - $90,372
-352 Reduced 1.99%
17,314 $4.21 Million
Q1 2022

Apr 14, 2022

SELL
$219.27 - $242.57 $2.17 Million - $2.4 Million
-9,886 Reduced 35.88%
17,666 $4.27 Million
Q4 2021

Jan 13, 2022

SELL
$198.88 - $227.6 $169,048 - $193,460
-850 Reduced 2.99%
27,552 $6.2 Million
Q3 2021

Oct 19, 2021

BUY
$212.27 - $248.7 $39,906 - $46,755
188 Added 0.67%
28,402 $6.04 Million
Q2 2021

Jul 16, 2021

SELL
$233.58 - $259.14 $108,848 - $120,759
-466 Reduced 1.62%
28,214 $6.88 Million
Q1 2021

Apr 20, 2021

BUY
$221.91 - $258.6 $516,828 - $602,279
2,329 Added 8.84%
28,680 $7.14 Million
Q4 2020

Jan 13, 2021

SELL
$216.38 - $257.67 $23,152 - $27,570
-107 Reduced 0.4%
26,351 $6.06 Million
Q3 2020

Oct 19, 2020

BUY
$234.65 - $260.95 $68,517 - $76,197
292 Added 1.12%
26,458 $6.73 Million
Q2 2020

Jul 14, 2020

BUY
$197.81 - $242.74 $32,638 - $40,052
165 Added 0.63%
26,166 $6.17 Million
Q1 2020

Apr 02, 2020

SELL
$182.24 - $241.7 $22,597 - $29,970
-124 Reduced 0.47%
26,001 $5.27 Million
Q4 2019

Jan 07, 2020

BUY
$189.21 - $243.2 $19,299 - $24,806
102 Added 0.39%
26,125 $6.3 Million
Q3 2019

Oct 25, 2019

BUY
$174.11 - $208.62 $25,245 - $30,249
145 Added 0.56%
26,023 $5.04 Million
Q2 2019

Jul 25, 2019

BUY
$166.7 - $195.41 $666 - $781
4 Added 0.02%
25,878 $4.77 Million
Q1 2019

Apr 23, 2019

BUY
$180.87 - $203.88 $69,996 - $78,901
387 Added 1.52%
25,874 $4.92 Million
Q4 2018

Jan 28, 2019

BUY
$178.4 - $208.25 $14,807 - $17,284
83 Added 0.33%
25,487 $4.96 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $4.71 Million - $5.31 Million
25,404 New
25,404 $5.27 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Mc Guire Investment Group, LLC Portfolio

Follow Mc Guire Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Guire Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mc Guire Investment Group, LLC with notifications on news.